Literature DB >> 16945426

CD4+ T and B cells cooperate in the immunoregulation of Experimental Autoimmune Myasthenia Gravis.

Monica Milani1, Norma Ostlie, Huiyun Wu, Wei Wang, Bianca M Conti-Fine.   

Abstract

C57Bl6 mice (B6 mice) immunized with Torpedo acetylcholine receptor (TAChR) in Freund's adjuvants (FA) develop Experimental Autoimmune Myasthenia Gravis (EAMG). In mouse EAMG Th2 cytokines may be protective. Aluminum hydroxide (Alum) was used to immunize B6 mice to the TAChR and prime CD4+ T and B cells secreting Th2 cytokines. Mice immunized with TAChR/Alum developed anti-AChR CD4+ T cells response, but minimal antibody levels and symptoms. TAChR/Alum treatments prior immunization with TAChR/FA protected mice from EAMG. Cell transfer experiments demonstrated that B and CD4+ T cells mediated the protective effect by causing intense reduction of complement-fixing anti-TAChR IgG subclasses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945426     DOI: 10.1016/j.jneuroim.2006.07.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

Review 1.  Inflammatory bowel disease, past, present and future: lessons from animal models.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

2.  Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses.

Authors:  Xiuhua Yao; Qingfei Kong; Xiaoli Xie; Jinghua Wang; Na Li; Yumei Liu; Bo Sun; Ying Li; Guangyou Wang; Wenjin Li; Siying Qu; Haijun Zhao; Dandan Wang; Xijun Liu; Yao Zhang; Lili Mu; Hulun Li
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

3.  Altered influenza virus haemagglutinin (HA)-derived peptide is potent therapy for CIA by inducing Th1 to Th2 shift.

Authors:  Jian Sun; Yuan Jia; Ru Li; Jianping Guo; Xiaolin Sun; Yanying Liu; Yingni Li; Haihong Yao; Xia Liu; Jing Zhao; Zhanguo Li
Journal:  Cell Mol Immunol       Date:  2011-03-07       Impact factor: 11.530

4.  Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.

Authors:  Huan Yang; Yong Zhang; Minghua Wu; Jing Li; Wenbin Zhou; Guiyuan Li; Xiaoling Li; Bo Xiao; Premkumar Christadoss
Journal:  Inflamm Res       Date:  2009-09-19       Impact factor: 4.575

Review 5.  Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.

Authors:  Marieke Robinet; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

6.  Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis.

Authors:  Lili Mu; Bo Sun; Qingfei Kong; Jinghua Wang; Guangyou Wang; Shujuan Zhang; Dandan Wang; Yumei Liu; Yixi Liu; Huixia An; Hulun Li
Journal:  Immunology       Date:  2009-03-23       Impact factor: 7.397

7.  Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs.

Authors:  Mario Losen; Pilar Martinez-Martinez; Peter C Molenaar; Konstantinos Lazaridis; Socrates Tzartos; Talma Brenner; Rui-Sheng Duan; Jie Luo; Jon Lindstrom; Linda Kusner
Journal:  Exp Neurol       Date:  2015-03-18       Impact factor: 5.330

8.  Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity.

Authors:  Peng Zhang; Chun-Lin Yang; Tong Du; Yu-Dong Liu; Meng-Ru Ge; Heng Li; Ru-Tao Liu; Cong-Cong Wang; Ying-Chun Dou; Rui-Sheng Duan
Journal:  J Neuroinflammation       Date:  2021-10-26       Impact factor: 8.322

9.  Lymphoplasma Exchange Improves Myasthenia Gravis Exacerbations: A Retrospective Study in a Chinese Center.

Authors:  Song Ouyang; Weifan Yin; Qiuming Zeng; Bijuan Li; Jian Zhang; Weiwei Duan; Yi Li; Yong Liang; Jiaqi Wang; Hong Tan; Huan Yang
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

10.  Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients.

Authors:  Xin Huang; Hao Ran; Yingkia Li; Qian Ma; Changyi Ou; Li Qiu; Huiyu Feng; Weibin Liu
Journal:  Front Neurol       Date:  2022-09-09       Impact factor: 4.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.